Group One Trading
ASND icon

Group One Trading’s Ascendis Pharma A/S ASND Stock Holding History

Group One Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
+4,019
New +$939K ﹤0.01% 2807
2025
Q3 		– Sell
-142
Closed -$26.5K – 8373
2025
Q2 		$24.5K Sell
142
-3,636
-96% -$592K ﹤0.01% 6124
2025
Q1 		$589K Sell
3,778
-323
-8% -$46.1K ﹤0.01% 2926
2024
Q4 		$565K Buy
+4,101
New +$539K ﹤0.01% 3071
2024
Q1 		– Sell
-5,808
Closed -$829K – 7018
2023
Q4 		$732K Buy
5,808
+2,964
+104% +$296K ﹤0.01% 2749
2023
Q3 		$266K Buy
+2,844
New +$266K ﹤0.01% 3555
2023
Q1 		– Sell
-1,235
Closed -$141K – 7176
2022
Q4 		$151K Sell
1,235
-16,130
-93% -$1.87M ﹤0.01% 4091
2022
Q3 		$1.79M Buy
17,365
+11,321
+187% +$1.07M ﹤0.01% 2011
2022
Q2 		$562K Buy
+6,044
New +$570K ﹤0.01% 3304
2021
Q3 		– Sell
-11
Closed -$1.5K – 8146
2021
Q2 		$1K Sell
11
-220
-95% -$29.3K ﹤0.01% 7996
2021
Q1 		$30K Sell
231
-710
-75% -$108K ﹤0.01% 6547
2020
Q4 		$157K Buy
+941
New +$156K ﹤0.01% 4238
2020
Q2 		– Sell
-569
Closed -$78.1K – 5769
2020
Q1 		$64K Sell
569
-1,219
-68% -$158K ﹤0.01% 3567
2019
Q4 		$249K Buy
1,788
+565
+46% +$62.8K ﹤0.01% 3010
2019
Q3 		$118K Sell
1,223
-4,392
-78% -$490K ﹤0.01% 3444
2019
Q2 		$647K Buy
+5,615
New +$672K 0.01% 1911
2019
Q1 		– Sell
-1,345
Closed -$118K – 4768
2018
Q4 		$84K Buy
+1,345
New +$84.5K ﹤0.01% 3280
2018
Q3 		– Sell
-98
Closed -$6.75K – 5163
2018
Q2 		$7K Buy
+98
New +$6.45K ﹤0.01% 4705

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Group One Trading's ASND Position: Q2 2026 in Review

Group One Trading opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 4,019 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings. This is a return to the name: Group One Trading previously reported a position in ASND as recently as Q2 2025.

Group One Trading first reported a position in ASND in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.79M in Q3 2022. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Group One Trading held 4,019 shares of Ascendis Pharma A/S worth $1.07M as of Q2 2026.
  • Ascendis Pharma A/S was a new Group One Trading position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2807 holding.
  • Group One Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 18 quarters since.
  • Group One Trading's Ascendis Pharma A/S position peaked at $1.79M in Q3 2022.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.